Indonesia Healthcare Market Outlook to 2022: Ken Research

1
Indonesia Healthcare Market Outlook to 2022 - by
Hospitals, Clinical Laboratories, Pharmaceutical,
Pharmacy Chains, Medical Device Segment Ken
Research
2
Indonesia Healthcare Market Outlook to 2022 - by
Hospitals, Clinical Laboratories, Pharmaceutical,
Pharmacy Chains, Medical Device Segment" provides
information on market size for Indonesia
Healthcare, hospital, pharmaceutical, pharmacy
retail, clinical laboratory and medical devices.
3
The report covers aspects such as healthcare
market segment (by hospitals, pharmaceuticals,
medical devices and clinical laboratory),
hospital market segment (by public private
hospitals, by general specialty hospitals and
by region), pharmaceutical market segment (by
therapeutic segment, by domestic international
players, by generic patented drug, by OTC
prescription drugs, by domestic sales exports
and by region), pharmacy retail market segment
(by pharmacies drugstores and by region),
4
Clinical laboratory market segment (by type of
clinical laboratory, by type of private
independent laboratory, by type of customer, by
payer, by type of test and by region) and medical
device market segment (by type of medical device,
by type of medical consumables, by end user and
by procurement), competitive landscape of major
Hospitals (Mitra Keluarga Karyasehat Tbk Pt,
Siloam Hospitals, PT Sejahteraraya Anugrahjaya,
Sarana Meditama, Rumah Sakit Pondok Indah, Surya
Husadha, Jakarta Eye Center), pharmaceutical
companies (PT Kalbe Farma, PT Sanbe Farma, PT
SOHO Global Health, PT Dexa Medica, PT Pharos, PT
Kimia Farma, PT Tempo Scan Pacific, PT Merck),
5
Pharmacy Retail (Guardian Pharmacy, Kimia Farma,
Apotek K-24, A S Watsons, Century Healthcare),
Diagnostic Laboratories (Prodia, Kimia Farma
Diagnostika, Pramita, Cito, BioMedika, Parahita),
Medical Devices Companies (GE Healthcare
Indonesia, Siemens Indonesia, Philips Indonesia,
PT Mensa Binasukses, PT Transmedic Indonesia).
The report concludes with market projection for
future and analyst recommendations highlighting
the major opportunities and cautions.
6
Indonesia Healthcare Market OverviewIndonesia
Healthcare market revenue has increased from USD
billion in 2012 to USD billion in 2017. The
healthcare market has increased on the account of
increasing healthcare facilities, innovation in
pharmaceutical manufacturers and clinical
laboratory services and expansion of pharmacy
retail chains across the country.
7
Market Segmentation Indonesia Hospital
MarketIndonesia Hospital Market grew from USD
million in the year 2012 to USD million in the
year 2017. Public hospitals have accounted for
of the number of hospitals on account of the
increase in the government budget allocation on
healthcare. Private hospitals have registered
of the total hospitals in Indonesia in 2016 as
the demand for modern medicine and specialist
services increased in the country.
8
By General and Specialty Hospitals General
hospitals have accounted for of the total
number of hospitals whereas specialty hospitals
which include hospitals such as mental hospital,
leprosy hospital, eye hospital and others have
registered of the total number of
hospitals. Indonesia Pharmaceutical
MarketIndonesia Pharmaceutical market has
registered an increase in the revenue at a CAGR
of from USD billion in 2012 to USD billion
in 2017.
9
By Therapeutic Segment Anti-infective drug sale
has contributed to the largest share of in the
revenue share of Indonesia Pharmaceutical
industry in 2017. This is followed by
Gastrointestinal and metabolism drugs with ,
cardiovascular system drugs with , Central
Nervous system drugs with , Respiratory system
drugs with , Musculoskeletal system drugs with
, dermatology drugs with , genitourinary and
hormonal drugs with , blood related drugs with
, oncology with and rest of the therapeutic
segments with of the revenue share in 2017.
10
By Domestic and International Players Domestic
players have accounted for of the revenue in
Indonesia pharmaceutical market in 2017 driven by
the implementation of JKN (National Health
Insurance System) in 2014. International players
have captured of the revenue share in 2017
driven by favorable government norms for foreign
ownership.
11
By Generic and Patented Drug Generic drugs have
accounted for the major revenue share of in
2017 driven by the increased demand from
government run hospitals and clinics. The share
of patented drugs has increased from in 2013
to in 2017. Further, ethical generic drugs
have accounted for of Indonesia generic drug
market revenue in 2017 followed by free sale
drugs with and unbranded drug sale with .
12
Indonesia Pharmacy Retail MarketIndonesia
pharmacy retail market revenue has escalated from
USD billion in 2012 to USD billion in 2017 at
a CAGR of . By Pharmacies and Drugstores
Pharmacies have registered of the revenue
share in Indonesia pharmacy retail market 2017
driven by higher margins and wider portfolio of
pharmacies. The drugstores which are licensed to
sell only medicinal drugs have accounted for
in 2017
13
By Region West Java has accounted for of the
total number of pharmacies and drugstores located
in Indonesia in 2015 driven by high population in
the region and presence of generic drug
manufacturers. This is followed by East Java with
, Central Java with , Jakarta with and
North Sumatra with of the pharmacies and
drugstores in Indonesia in 2015. Rest of
Indonesia has accounted for of the drugstores.
14
Indonesia Clinical Laboratory MarketIndonesia
clinical laboratory market increased from USD
million in 2012 to USD million in 2017 at a
CAGR of . By Type of Laboratory The public
clinical labs have accounted for of the
revenue share in Indonesia clinical laboratory
market in 2017. Private hospital labs have
accounted for in 2017 and private independent
labs with of the overall market.
15
By Type of Private Independent Laboratory The
laboratory chains such as Prodia, Kimia Farma
Diagnostik, Pramita, Cito, BioMedika and Parahita
have together accounted for of revenue the
overall private independent laboratory market in
2016. Single independent labs have contributed to
their lower revenue share of due to their
restricted geographic presence. By Type of Tests
in Private Independent Laboratory Routine tests
have accounted for of the revenue in Indonesia
Private independent laboratory market in 2016.
This is followed by esoteric tests with and
non laboratory tests with of the overall
private independent laboratory market.
16
Indonesia Medical Device MarketIndonesia Medical
device revenue increased from USD billion in
2012 to USD billion in 2017 at a CAGR of By
Type of Medical Device Diagnostic imaging
products have accounted for the largest share of
of the revenue share in Indonesia Medical
Devices market in 2017. This is followed by
medical consumable product with , aesthetic
devices with , auxiliary devices with ,
dental products with and orthopedic implants
with . Others which include Point of Care
Testing devices, radiation oncology devices,
therapy system and testing and measurement
systems have accounted for of the overall
market revenue.
17
By Procurement Imports have accounted for of
the revenue share in Indonesia Medical Device
Market in 2017. The imports are largely related
to more sophisticated medical and surgical
instruments and infrastructure. The share of
local companies in the market revenue has
increased from in 2014 to in 2017.
18
Snapshot on Indonesia Polyclinic MarketDemand
for various healthcare services in the country
has escalated over the past five years owing to
increased prevalence of various life-style
related diseases such as Diabetes, Obesity,
Hypertension, Blood Pressure, Cardio vascular
diseases and expanding population base of the
country over the last five years has cemented the
polyclinic markets position as a major
healthcare service provider in the country.
Majority of people in Indonesia have preferred
polyclinics over hospitals in the past few years
due to convenience and lower cost of healthcare
services. The number of Puskesmas in Indonesia
has increased from in 2012 to in 2016.
19
Key Topics Covered in the Report Indonesia
Healthcare, Hospitals, Pharmaceutical, Pharmacy
Retail, Clinical Laboratory, Medical Devices
Market Size, 2012-2017 Indonesia Hospitals Market
Segmentation (by public private hospitals, by
general specialty hospitals and by
region) Indonesia Hospitals, Pharmaceutical,
Pharmacy Retail, Clinical Laboratory, Medical
Devices Market Competitive Landscape Indonesia
Hospital, Pharmaceutical, Pharmacy Retail,
Clinical Laboratory, Medical Devices Future
Outlook and Projections, 2018-2022
20
Indonesia Pharmaceuticals Market Segmentation (by
therapeutic segment, by domestic international
players, by generic patented drug, by OTC
prescription drugs, by domestic sales exports
and by region) Indonesia Pharmacy Retail Market
Segmentation (by pharmacies drugstores and by
region) Indonesia Clinical Laboratory Market
Segmentation (by type of clinical laboratory, by
type of private independent laboratory, by type
of customer, by payer, by type of test and by
region) Indonesia Medical Devices Market
Segmentation (by type of medical device, by type
of medical consumables, by end user and by
procurement) Analyst Recommendations Macro-economi
c Factors Impacting Indonesia Healthcare Market  
21
Source https//www.kenresearch.com/healthcare/gen
eral-healthcare/indonesia-healthcare-market/143541
-91.html Contact UsKen ResearchAnkur Gupta,
Head Marketing Communicationsankur _at_
kenresearch.com91-9015378249